VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRHIPresurance Holdings, Inc.
$5.13$10M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRHIQuarterly Financials

Presurance Holdings, Inc. (PRHI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Presurance Holdings, Inc. (PRHI) quarterly income statement — complete revenue, gross profit & net income history

PRHI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue7.06M6.5M8.18M10.78M11.48M13.75M16.02M17.9M18.63M16.37M25.44M24.92M
Revenue Growth %-38.53%-52.71%-48.94%-39.79%-38.36%-15.99%-37.04%-28.17%-24.22%-34.77%-3.4%0.97%
Medical Costs & Claims4.89M17.86M8.28M8.85M11.95M35.88M18.4M18.67M13.68M35.5M25.31M23.73M
Medical Cost Ratio %69.25%274.6%101.28%82.11%104.1%260.94%114.88%104.31%73.45%216.89%99.49%95.22%
Gross Profit2.17M-11.36M-105K1.93M-471K-22.13M-2.38M-771K4.95M16.37M129K1.19M
Gross Margin %30.75%-174.6%-1.28%17.89%-4.1%-160.94%-14.88%-4.31%26.55%100%0.51%4.78%
Gross Profit Growth %560.72%48.69%95.6%350.06%-109.52%-235.21%-1948.06%-164.74%-19.53%492.92%-96.24%136.17%
Operating Expenses-414K5.54M3.87M-123K-993K3.05M5.87M3.29M3.74M3.97M4.95M5.93M
OpEx / Revenue %-5.87%85.24%47.26%-1.14%-8.65%22.2%36.64%18.38%20.08%24.25%19.45%23.81%
Depreciation & Amortization63K64K63K64K64K459K891K173K148K153K199K95K
Combined Ratio %63.38%359.84%148.54%80.97%95.45%283.14%151.53%122.68%93.52%241.14%118.94%119.03%
Operating Income2.58M-16.9M-3.97M2.05M522K-25.18M-8.25M-4.06M1.21M12.4M-4.82M-4.74M
Operating Margin %36.62%-259.84%-48.54%19.03%4.55%-183.14%-51.53%-22.68%6.48%75.75%-18.94%-19.03%
Operating Income Growth %395.02%32.9%51.9%150.5%-56.72%-303.1%-71.26%14.38%2.2%270.1%-179.69%44.13%
EBITDA2.65M-16.84M-3.91M2.12M586K-24.73M-7.36M-3.89M1.35M12.55M-4.62M-4.65M
EBITDA Margin %37.51%-258.86%-47.77%19.62%5.1%-179.8%-45.96%-21.72%7.27%76.69%-18.16%-18.65%
Interest Expense1.98M906K874K864K541K862K2.27M868K877K845K855K820K
Non-Operating Income-1.98M-906K-874K-864K-541K-862K-2.27M-868K-877K12.4M-855K-820K
Pretax Income2.58M-16.9M-3.97M2.05M522K-25.18M-8.25M-4.06M1.21M-19.31M-4.82M-4.74M
Pretax Margin %36.62%-259.84%-48.54%19.03%4.55%-183.14%-51.53%-22.68%6.48%-117.95%-18.94%-19.03%
Income Tax-38K141K00011K-1.37M-333K-151K111K-457K-4K
Effective Tax Rate %-1.47%-0.83%0%0%0%-0.04%16.56%8.2%-12.52%-0.57%9.48%0.08%
Net Income2.62M-17.04M-3.97M2.05M522K-25.38M53.29M-3.79M231K-19.46M-2.71M-4.74M
Net Margin %37.15%-262.01%-48.54%19.03%4.55%-184.57%332.71%-21.18%1.24%-118.88%-10.64%-19.01%
Net Income Growth %402.3%32.86%-107.45%154.09%125.97%-30.43%2069.33%19.98%-76.92%-1021.84%-77.68%43.58%
EPS (Diluted)1.05-9.80-2.241.190.30-14.5630.24-2.240.04-11.13-1.54-2.73
EPS Growth %251.29%32.69%-107.41%153.13%611.67%-30.82%2063.64%17.95%-92.5%-1035.29%-57.14%54.65%
EPS (Basic)1.05-9.80-2.241.190.30-14.5630.24-2.240.04-11.13-1.54-2.73
Diluted Shares Outstanding1.75M1.75M1.75M1.75M1.75M1.75M1.75M1.75M1.75M1.75M1.75M1.75M